These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1237 related articles for article (PubMed ID: 30232451)

  • 21. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
    Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
    J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accelerated tau pathology with synaptic and neuronal loss in a novel triple transgenic mouse model of Alzheimer's disease.
    Saul A; Sprenger F; Bayer TA; Wirths O
    Neurobiol Aging; 2013 Nov; 34(11):2564-73. PubMed ID: 23747045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cortical neuronal and glial pathology in TgTauP301L transgenic mice: neuronal degeneration, memory disturbance, and phenotypic variation.
    Murakami T; Paitel E; Kawarabayashi T; Ikeda M; Chishti MA; Janus C; Matsubara E; Sasaki A; Kawarai T; Phinney AL; Harigaya Y; Horne P; Egashira N; Mishima K; Hanna A; Yang J; Iwasaki K; Takahashi M; Fujiwara M; Ishiguro K; Bergeron C; Carlson GA; Abe K; Westaway D; St George-Hyslop P; Shoji M
    Am J Pathol; 2006 Oct; 169(4):1365-75. PubMed ID: 17003492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
    Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
    Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Senescent Cells in the Bone Microenvironment.
    Farr JN; Fraser DG; Wang H; Jaehn K; Ogrodnik MB; Weivoda MM; Drake MT; Tchkonia T; LeBrasseur NK; Kirkland JL; Bonewald LF; Pignolo RJ; Monroe DG; Khosla S
    J Bone Miner Res; 2016 Nov; 31(11):1920-1929. PubMed ID: 27341653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular Senescence as the Key Intermediate in Tau-Mediated Neurodegeneration.
    Mendelsohn AR; Larrick JW
    Rejuvenation Res; 2018 Dec; 21(6):572-579. PubMed ID: 30489222
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenosine A
    Zhao ZA; Zhao Y; Ning YL; Yang N; Peng Y; Li P; Chen XY; Liu D; Wang H; Chen X; Bai W; Chen JF; Zhou YG
    Transl Psychiatry; 2017 May; 7(5):e1123. PubMed ID: 28485728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clearance of senescent cells by ABT263 rejuvenates aged hematopoietic stem cells in mice.
    Chang J; Wang Y; Shao L; Laberge RM; Demaria M; Campisi J; Janakiraman K; Sharpless NE; Ding S; Feng W; Luo Y; Wang X; Aykin-Burns N; Krager K; Ponnappan U; Hauer-Jensen M; Meng A; Zhou D
    Nat Med; 2016 Jan; 22(1):78-83. PubMed ID: 26657143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.
    Onishi T; Matsumoto Y; Hattori M; Obayashi Y; Nakamura K; Yano T; Horiguchi T; Iwashita H
    Neurosci Res; 2014 Mar; 80():76-85. PubMed ID: 24406748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
    J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Astrocyte senescence and SASP in neurodegeneration: tau joins the loop.
    Ungerleider K; Beck J; Lissa D; Turnquist C; Horikawa I; Harris BT; Harris CC
    Cell Cycle; 2021 Apr; 20(8):752-764. PubMed ID: 33818291
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Nrf2 loss on senescence and cognition of tau-based P301S mice.
    Riordan R; Rong W; Yu Z; Ross G; Valerio J; Dimas-Muñoz J; Heredia V; Magnusson K; Galvan V; Perez VI
    Geroscience; 2023 Jun; 45(3):1451-1469. PubMed ID: 36976489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM).
    Canudas AM; Gutierrez-Cuesta J; Rodríguez MI; Acuña-Castroviejo D; Sureda FX; Camins A; Pallàs M
    Mech Ageing Dev; 2005 Dec; 126(12):1300-4. PubMed ID: 16171847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p16(Ink4a) and senescence-associated β-galactosidase can be induced in macrophages as part of a reversible response to physiological stimuli.
    Hall BM; Balan V; Gleiberman AS; Strom E; Krasnov P; Virtuoso LP; Rydkina E; Vujcic S; Balan K; Gitlin II; Leonova KI; Consiglio CR; Gollnick SO; Chernova OB; Gudkov AV
    Aging (Albany NY); 2017 Aug; 9(8):1867-1884. PubMed ID: 28768895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High copy wildtype human 1N4R tau expression promotes early pathological tauopathy accompanied by cognitive deficits without progressive neurofibrillary degeneration.
    Wheeler JM; McMillan PJ; Hawk M; Iba M; Robinson L; Xu GJ; Dombroski BA; Jeong D; Dichter MA; Juul H; Loomis E; Raskind M; Leverenz JB; Trojanowski JQ; Lee VM; Schellenberg GD; Kraemer BC
    Acta Neuropathol Commun; 2015 Jun; 3():33. PubMed ID: 26041339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
    Engel T; Goñi-Oliver P; Lucas JJ; Avila J; Hernández F
    J Neurochem; 2006 Dec; 99(6):1445-55. PubMed ID: 17059563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Senescence Targeting Methods Impact Alzheimer's Disease Features in 3xTg Mice.
    Ng PY; Zhang C; Li H; Baker DJ
    J Alzheimers Dis; 2024; 97(4):1751-1763. PubMed ID: 38306030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
    Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
    J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.